Our study demonstrated that circHIPK3 interference ameliorated apoptosis, inflammatory factors, and oxidative stress via the miR-338/FOXA1 axis in sepsis-induced AKI, suggesting that circHIPK3 might be a potential biomarker and therapeutic target for sepsis-induced AKI patients. This evidence concerns the gene FOXA1 and acute kidney injury.